25 results on '"Bijl, Tom"'
Search Results
2. Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
3. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
4. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
5. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
6. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
7. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
8. Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
9. Identification of New Drugs to Counteract Anti-Spike IgG-Induced Hyperinflammation in Severe COVID-19
10. Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
11. Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
12. Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
13. Lassa virus glycoprotein nanoparticles elicit a neutralizing antibody that defines a new site of vulnerability
14. HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies
15. Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection
16. A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike
17. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
18. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
19. Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
20. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
21. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
22. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
23. The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine.
24. Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19.
25. Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.